FDA Approves Turalio (Pexidartinib) for TGCT
Kinase inhibitor oral capsules.
Improving Business Performance Through Data Driven Solutions
Caring for patients requires a successful business.
ThoughtSpot 2019 General Session Fireside Chat
New Guidelines Stress Pharmacist Well-Being
50 new recommendations signed by organizations, schools, and regulators.
HHS, FDA Unveil Drug Importation Plan
Update: ASHP statement released.
The Need for Trauma Team Pharmacists
Survey indicates need for greater pharmacist presence.
Birth Weight, Due Date, and COPD
Natal conditions may influence susceptibility.
Opinion: Staying Afloat
PBMs are making it nearly impossible to navigate the waters of healthcare, writes Kreckle.
ASHP Releases New Guidelines for Perioperative Pharmacists
How to handle controlled substances and medication safely.
Why Advocacy and Social Media Outreach Works
New platforms can increase exposure and traffic in your stores.
Telling Pharmacists’ Stories in a Digital Age
Good Neighbor Pharmacy's transition from broadcast to digital marketing.
A Word from AmerisourceBergen’s Rich Tremonte at ThoughtSpot 2019
ThoughtSpot 2019 In Review
New Warnings for Tofacitinib Issued by FDA
Black box warns of increased risk of blood clots and death.
The Pros and Cons of Pharmacy Automation
Dispensing robots began rolling out to retail and ambulatory care pharmacies in the 1990s.
Testing Recommendations for Hepatitis C
Supporting the Value of Independent Pharmacy and Pharmaceutical Care
Independent pharmacies differentiate with service and high-touch care.
Pharmacists at the FDA: Drug Information Specialists
Agents of regulatory guidance, drug problem reports, and whistleblowers.
FDA Issues Warning to CBD Product Suppliers
Companies have been promoting unsubstantiated health and treatment claims.
CPF and CPESN USA: Flip the Pharmacy
New program to fund community pharmacy reinvention efforts.
FDA Approves Hadlima (Adalimumab-bwwd) Biosimilar
TNF blocker biosimilar to Humira (adalimumab, Abbvie).
Opioid Prescriptions Are Still Prolific, But Deaths Fall
76 billion opioid pain pills distributed from 2012-2016.
FDA Approves Ruxience, a Rituxan Biosimilar
CD20-directed antibody indicated for several cancers and other conditions.
Criminal Opioid Charges Piling Up Against Pharmacists, Distributors
Prosecutors are bringing accountability to the opioid epidemic.
Getting to Know AmerisourceBergen’s Rich Tremonte
Q&A from ThoughtSpot 2019.
First Generic Lyrica Capsules Approved by FDA
Distributed by Invagen, a subsidiary of Cipla Ltd.
Compounding Industry on the Newest MOU Draft
FDA plans to finalize the draft in 2019.
4 Ways Precision Medicine Impacts Cancer Treatment
How targeted therapy could be the pathway to improved cancer treatment.
FDA Approves Otezla (Apremilast) to Treat Oral Ulcers
Fourth indication for the drug since 2014.
Researchers Exploring Oral Flu Vaccine and Treatment Options
Biotech companies join forces to develop oral flu vaccines.
